Modalities Phase I Sample Clauses

Modalities Phase I. This phase begins with the initialing of the Lusaka Accords between the Government of the Republic of Angola and UNITA, and continues until the quartering of UNITA military forces. Setting up of a working group to supervise the completion of the formation of FAA and demobilization within the framework of the joint commission to be established under the new United Nations mandate. The above-mentioned working group will comprise representatives of the United Nations, the Angolan Government and UNITA. The work of this group will be based on information made available to the United Nations by the Government of Angola and UNITA with regard to the personnel, the composition and location of the respective military forces as well as the deliberations of the meeting between the general staffs of FAA and UNITA. The working group will be responsible for monitoring the following tasks concerning the completion of the formation of FAA and demobilization: Selection criteria Size of FAA to be agreed between the Government of the Republic of Angola and UNITA Adequacy of the composition of FAA, based on the principle of proportionality: in the case of the army, the principle of parity shall apply; in the case of the Navy and the Air Force, UNITA military forces shall be incorporated in conformity with the provisions established by CCFA ("Acordos xx Xxx") and instructions from the General Staff of FAA. Identification of the location and rehabilitation of the already existing military training centers Identification of the location and rehabilitation of the already existing vocational training centers for the soldiers to be demobilized Identification of the location as well as construction and rehabilitation of quarters for the FAA units The resources necessary for military incorporation based on the skills and specializations of FAA personnel Logistics and administrative resources for all the tasks Phase II This phase begins with the completion of the quartering of UNITA military forces and ends with the commencement of movement to the centers for the vocational training of the demobilized military personnel. Stage I Return of the UNITA generals who left FAA. Stage II Dissolution of the working group mentioned under Phase I and assumption by the FAA General Staff of its functions with regard to the completion of the formation of the Angolan Armed Forces and demobilization. Stage III Establishment of a working group, under the FAA General Staff, which will operate in the are...
Sample 1Sample 2
AutoNDA by SimpleDocs

Related to Modalities Phase I

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Geological and Archeological Specimens If, during the execution of the Work, the Contractor, any Subcontractor, or any servant, employee, or agent of either should uncover any valuable material or materials, such as, but not limited to, treasure trove, geological specimens, archival material, archeological specimens, or ore, the Contractor acknowledges that title to the foregoing is vested in the Owner. The Contractor shall notify the Owner upon the discovery of any of the foregoing, shall take reasonable steps to safeguard it, and seek further instruction from the Design Professional. Any additional cost incurred by the Contractor shall be addressed under the provision for changed conditions. The Contractor agrees that the Geological and Water Resources Division and the Historic Preservation Division of the Georgia Department of Natural Resources may inspect the Work at reasonable times.

  • Sites Sites shall mean the locations set forth in the Contract Documentation.

  • MANAGEMENT OF EVALUATION OUTCOMES 12.1 The evaluation of the Employee’s performance will form the basis for rewarding outstanding performance or correcting unacceptable performance.

  • Infrastructure Vulnerability Scanning Supplier will scan its internal environments (e.g., servers, network devices, etc.) related to Deliverables monthly and external environments related to Deliverables weekly. Supplier will have a defined process to address any findings but will ensure that any high-risk vulnerabilities are addressed within 30 days.

  • Programming Phase 2.2.1.2. Schematic Design Phase: 2.2.1.3. Design Development Phase:

  • Tuberculosis Examination The examination shall consist of an approved intradermal tuberculosis test, which, if positive, shall be followed by an X-ray of the lungs. Nothing in Sections 5163 to 5163.2, inclusive, shall prevent the governing body of any city or county, upon recommendation of the local health officer, from establishing a rule requiring a more extensive or more frequent examination than required by Section 5163 and this section. § 5163.2. Technician taking X-ray film; Interpretation of X-ray The X-ray film may be taken by a competent and qualified X-ray technician if the X-ray film is subsequently interpreted by a licensed physician and surgeon.

  • Protocol No action to coerce or censor or penalize any negotiation participant shall be made or implied by any other member as a result of participation in the negotiation process.

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK Firms and/or individuals that assisted in the development or drafting of the specifications, requirements, statements of work, or solicitation documents contained herein are excluded from competing for this solicitation. This shall not be applicable to firms and/or individuals providing responses to a publicly posted Request for Information (RFI) associated with a solicitation.

Time is Money Join Law Insider Premium to draft better contracts faster.